In vitro activity of A-56619 (difloxacin), A-56620, and other new quinolone antimicrobial agents against genital pathogens.
AUTOR(ES)
Liebowitz, L D
RESUMO
The in vitro activities of two new carboxyquinolones, A-56619 (difloxacin) and A-56620, were compared with those of ciprofloxacin, norfloxacin, and ofloxacin against genital tract pathogens. All the quinolones were highly active against Neisseria gonorrhoeae. A-56619 had the lowest MICs against Chlamydia trachomatis (MIC range, 0.125 to 0.25 micrograms/ml) and Haemophilus ducreyi (MIC for 90% of isolates tested, 0.1 micrograms/ml).
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=180627Documentos Relacionados
- In vitro activity of difloxacin hydrochloride (A-56619), A-56620, and cefixime (CL 284,635; FK 027) against selected genital pathogens.
- In vitro activities of the quinolone antimicrobial agents A-56619 and A-56620.
- In vitro evaluation of A-56619 and A-56620, two new quinolones.
- In vitro activity of A-56619 and A56620, two new aryl-fluoroquinolone antimicrobial agents.
- In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
